Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-19T04:39:22.539Z Has data issue: false hasContentIssue false
  • English
  • Français

Onset properties of mivacurium measured by mechanomyography depend on the twitch height of the adductor pollicis muscle

Published online by Cambridge University Press:  04 May 2006

R. Hofmockel ,
B. Pohl ,
J. Bajorat  and
M. Blobner
R. Hofmockel
Affiliation:
Klinik für Anästhesiologie und Intensivtherapie der Universität Rostock, Rostock, Germany
B. Pohl
Affiliation:
Klinik für Anästhesiologie und Intensivtherapie der Universität Rostock, Rostock, Germany
J. Bajorat
Affiliation:
Klinik für Anästhesiologie und Intensivtherapie der Universität Rostock, Rostock, Germany
M. Blobner
Affiliation:
Klinik für Anästhesiologie der Technischen Universität München, Munich, Germany
Get access

Extract

Summary

Introduction: The influence of the twitch height of the adductor pollicis muscle during baseline measurements on the pharmacodynamic parameters of mivacurium was prospectively evaluated. Patients and methods: Fifty adult patients were anaesthetized with propofol and alfentanil. Neuromuscular function was monitored mechanomyographically by measuring the force of the adductor pollicis muscle following stimulation of the ulnar nerve. Following a stabilization period of 20 min, the individual twitch height of the adductor pollicis muscle was determined before a single bolus of mivacurium (75 μg kg−1) was administered. Patients were divided into two groups. The data of patients whose thumb adduction force was below the median value of all patients were the ‘low force’ group (9.1 ± 1.4 N) and the data of all other patients were the ‘high force’ group (13.7 ± 1.8 N). Results: In the ‘high force’ group, maximum neuromuscular blockade of mivacurium was deeper (0.97 ± 0.05 vs. 0.93 ± 0.06; P < 0.05) and onset faster (2.9 ± 1.1 min vs. 4.0 ± 1.2 min; P < 0.05). Neuromuscular recovery did not differ between the groups. Conclusion: The different onset speeds reflect either different sensitivity to neuromuscular blocking agents with respect to patients' muscle power or a problem of the mechanomyographic measuring technique.

Keywords

NEUROMUSCULAR BLOCKADE, monitoring, mechanomyographyNEUROMUSCULAR BLOCKING AGENTS, mivacuriumMUSCLES, adductor pollicisMUSLCE CONTRACTION, force
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 24 , Issue 1 , January 2007 , pp. 82 - 86
Copyright
© 2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Katz RL. A nerve stimulator for the continuous monitoring of muscle relaxant action. Anesthesiology 1965; 26: 832–833.Google Scholar
Viby-Mogensen J. Clinical assessment of neuromuscular transmission. Br J Anaesth 1982; 54: 209–223.Google Scholar
Viby Mogensen J, Engbaek J, Eriksson L et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59–74.Google Scholar
Ali H, Savarese JJ. Monitoring of neuromuscular function. Anesthesiology 1976; 45: 216–249.Google Scholar
Donlon Jr JV, Savarese JJ, Ali HH. Cumulative dose– response curves for gallamine: effect of altered resting thumb tension and mode of stimulation. Anesth Analg 1979; 58: 377–381.Google Scholar
Meretoja OA, Taivainen T, Brandom BW, Wirtavuori K. Frequency of train-of-four stimulation influences neuromuscular response. Br J Anaesth 1994; 72: 686–687.Google Scholar
McCoy EP, Mirakhur RK, Connolly FM, Loan PB. The influence of the duration of control stimulation on the onset and recovery of neuromuscular block. Anesth Analg 1995; 80: 364–367.Google Scholar
Lee GC, Iyengar S, Szenohradszky J et al. Improving the design of muscle relaxant studies. Stabilization period and tetanic recruitment. Anesthesiology 1997; 86: 48–54.Google Scholar
Le Corre F, Plaud B, Benhamou E, Debaene B. Visual estimation of onset time at the orbicularis oculi after five muscle relaxants: application to clinical monitoring of tracheal intubation. Anesth Analg 1999; 89: 1305–1310.Google Scholar
Plaud B, Debaene B, Lequeau F, Meistelman C, Donati F. Mivacurium neuromuscular block at the adductor muscles of the larynx and adductor pollicis in humans. Anesthesiology 1996; 85: 77–81.Google Scholar
Ibebunjo C, Srikant CB, Donati F. Properties of fibres, endplates and acetylcholine receptors in the diaphragm, masseter, laryngeal, abdominal and limb muscles in the goat. Can J Anaesth 1996; 43: 475–484.Google Scholar
Ibebunjo C, Srikant CB, Donati F. Duration of succinylcholine and vecuronium blockade but not potency correlates with the ratio of endplate size to fibre size in seven muscles in the goat. Can J Anaesth 1996; 43: 485–494.Google Scholar
Ibebunjo C, Hall LW. Muscle fibre diameter and sensitivity to neuromuscular blocking drugs. Br J Anaesth 1993; 71: 732–733.Google Scholar
Goat VA, Yeung ML, Blakeney C, Feldman SA. The effect of blood flow upon the activity of gallamine triethiodide. Br J Anaesth 1976; 48: 69–73.Google Scholar
Eriksson LI, Lennmarken C, Jensen E, Viby Mogensen J. Twitch tension and train-of-four ratio during prolonged neuromuscular monitoring at different peripheral temperatures. Acta Anaesthesiol Scand 1991; 35: 247–252.Google Scholar
Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M. Einsatz des neuromuskulären Monitorings in Deutschland. Der Anaesthesist 2003; 52: 522–526.Google Scholar
Blobner M, Söhnel A, van de Roemer A et al. Anwendung von Muskelrelaxanzien in Deutschland – eine Umfrage an deutschen Anästhesieeinrichtungen. Der Anaesthesist 2003; 52: 427–434.Google Scholar
Gatke MR, Viby-Mogensen J, Rosenstock C, Jensen FS, Skovgaard LT. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand 2002; 46: 207–213.Google Scholar
Peterson CR, Wise CS. Electromyographic method for objective measurement of muscle relaxant drugs. Arch Phys Med Rehabil 1961; 42: 566–572.Google Scholar